http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0446120-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D227-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 1990-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_359686b361f662f7927561f4cf1b20c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_980abb069168c530fda3e693dee0c7d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94a8880b53263760b337198e366494a2
publicationDate 1992-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0446120-A
titleOfInvention Arteralization inhibiting agent
abstract PURPOSE: To provide a low toxic arteralization-inhibiting agent containing a herbimycin derivative as an active ingredient. n CONSTITUTION: The objective agent contains a compound of formula I (R 1 , R 2 are Cl, or both are bonded to each other, when R 1 , R 2 are Cl, R 3 and R 4 , R 5 and R 6 both are bonded to each other, R 7 , R 8 are H; when R 1 and R 2 are bonded to each other, R 3 is OCH 3 , Cl, R 7 is H, group of formula II, R 3 is H, Br, R 4 is OCONH 2 , R 5 and R 6 form O or a bond together, or R 4 and R 5 form O-CO-O together and R 6 is Br) as an active ingredient. The compound is useful for preventing or treating various diseases caused by the abnormal multiplication of blood vessels, such as rheumatic arthritis, diabetic retinopathy, immature baby retinopathy, senile macular degeneration and excessive cicarrix formation when wound is healed. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7241754-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6552066-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7259156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6870049-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7405208-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6872715-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6887993-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6855705-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7381848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7291610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7378407-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9737650-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7235540-B2
priorityDate 1990-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226419605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517906

Total number of triples: 32.